Xiaoting Ma
Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, No.1 Shuaifuyuan, Dongcheng District
Beijing, 100730, China
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
First-line PD-1 inhibitor plus chemotherapy improves outcomes in advanced gastric cancer and correlates with specific biomarkers in a real-world cohort.
Journal: Discover oncology
Published: December 15, 2025
Treatment of metastatic pancreatic cancer with concurrent BRAF V600E mutation and germline BRCA2 mutation: a case report.
Journal: Chinese clinical oncology
Published: October 13, 2025
Efficacy and safety of fruquintinib combined with albumin-bound paclitaxel as second-line therapy for advanced gastric cancer following failure of PD-1 inhibitor-containing treatment (TACTIC GC-01): A phase II single-arm study.
Journal: International journal of cancer
Published: August 07, 2025
Development and validation of a clinical prognostic model for BRAF V600E-mutated colorectal cancer patients based on pathological stage, microsatellite status, and primary tumor site.
Journal: Frontiers in oncology
Published: July 08, 2024
Autologous CIK cells combined with chemotherapy as the first-line treatment for locally advanced or metastatic gastric cancer is safe and feasible.
Journal: Frontiers in immunology
Published: July 26, 2023
Advanced pancreatic cancer with KRAS wild-type and EGFR-sensitive mutation respond favorably to furmonertinib: A case report.
Journal: Frontiers in oncology
Published: January 25, 2023
Real-World Results of Raltitrexed Combined with S-1 and Bevacizumab in Heavily Pretreated Metastatic Colorectal Cancer.
Journal: Cancer management and research
Published: November 21, 2022
Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation.
Journal: Translational oncology
Published: October 24, 2022
Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapy.
Journal: Asia-Pacific journal of clinical oncology
Published: October 24, 2022
Downregulation of ITGβ3 in colon adenocarcinoma reveals poor prognosis by affecting genome stability, cell cycle, and the tumor immune microenvironment.
Journal: Frontiers in oncology
Published: September 18, 2022
Last Updated: 09/26/2026